Please take a moment to review the latest ASCO News
- Senators Richard Burr and Ben Cardin Recognized as ASCO Congressional Champions for Cancer Care
- Jasmine Kamboj, MD, Named ASCO Advocate of the Year
- FDA Permits Accelerated Approval to Sacituzumab Govitecan for Advanced Urothelial Cancer
- Watch Now: Discussion on Eligibility Criteria and the Impact on Access to Clinical Trials
- President’s Budget Proposal Provides Important Investments in Biomedical Research
- FDA Grants Regular Approval to Sacituzumab Govitecan for Triple-negative Breast Cancer
- Oncology Summer Internship Program Aims to Increase Diversity in Oncology Workforce
- FDA Approves New Dosing Regimen for Cetuximab
- FDA Approved Isatuximab-irfc for Multiple Myeloma
- Congress Expected to Extend Moratorium on Medicare Sequestration Cuts Through End of 2021; Claims on Hold Begins April 1
- Help Advance Cancer Policy Priorities During ASCO Advocacy Summit Week of Action: April 12-16
- FDA Approves Idecabtagene Vicleucel for Multiple Myeloma
- New Savings on HealthCare.gov Follow COVID Relief Package; Special Enrollment in Federal Insurance Marketplace Open Until August 15
- More Than 300 Stakeholder Groups Support Improved Access to Multi-Cancer Early Detection Tests
- FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma